FDA Panel Will Weigh Benefits, Risks Of Pfizer's COVID-19 Vaccine

Retrieved on: 2020-12-10 12:22:30

Tags for this article:

Medicine

Vaccines

Food and Drug Administration

Vaccine

Influenza vaccine

Helen Petousis-Harris

Richard Harris

Click the tags to see associated articles and topics

FDA Panel Will Weigh Benefits, Risks Of Pfizer's COVID-19 Vaccine. View article details on hiswai:

Excerpt

A federal advisory committee is evaluating <b>Pfizer's</b> COVID-19 vaccine. The Food and Drug Administration will weigh that input as it decides whether to ...

Article found on: www.npr.org

View Original Article